NORTH CENTRAL SURGICAL HOSPITAL — History
CCN 670049 | 3-year financial timeline | COVID resilience: 62/100
🛡️ Public data only — no PHI permitted on this instance.
$144M
Latest Revenue (FY2022)
+11.2%
Revenue CAGR (3yr)
32.0%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $116M | $137M | $144M | +4.9% | +11.2% |
| Operating Expenses | $77M | $92M | $98M | +6.1% | +12.7% |
| Operating Margin | 33.8% | 32.8% | 32.0% | -2.4% | -2.7% |
| Net Income | $39M | $45M | $46M | +2.4% | +8.2% |
| Licensed Beds | 24 | 24 | 24 | +0.0% | +0.0% |
| Total Patient Days | 3,096 | 3,380 | 2,428 | -28.2% | -11.4% |
| Medicare Day % | 38% | 43% | 47% | +8.1% | +10.9% |
| Medicaid Day % | nan% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 62/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +23.6% ($116M → $144M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+11.2%
This Hospital
+7.6%
State Avg
Latest Margin
32.0%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $157M | 31.1% |
| FY2024 (proj) | $171M | 30.2% |
| FY2025 (proj) | $185M | 29.3% |